Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
A few studies in patients with reactive thrombocytosis identified levels of the hormone higher than expected, and suggested that TPO behaves as an acute-phase protein and was responsible for increased platelet count. At the opposite, other studies did not find any significant rise of the hormone in patients who similarly developed reactive thrombocytosis. To gain further information on this topic, we compared TPO levels and platelet counts in two series of patients hospitalized for acute illnesses: one with strong elevation of both erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), and the other with normal values. Within the group of subjects with high ESR and CRP, 38 had normal platelet counts, while 15 had thrombocytosis. No thrombocytosis was observed in control patients. Patients with high acute phase indexes had significantly higher TPO levels and platelet counts than control patients. We identified significant positive correlations between ESR and CRP, and between TPO and CRP. Interestingly, no significant relationship between platelet counts and TPO levels was find. When we grouped patients with acute-phase reaction according to absence or presence of thrombocytosis, we found similar TPO values. Conversely, positive correlations between platelet count and IL-6 and between TPO and IL-6 have been identified. All together our results confirm that TPO acts as an acute phase protein but exclude the possibility that it is uniquely responsible for thrombocytosis of inflammatory disorders, which might recognize in IL-6 a credible candidate as a cooperating factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As detailed elsewhere in this special issue, both absolute ID and inflammation can also result in thrombocytosis due to the effects of altered thrombopoietin, EPO, and IL-6 levels on megakaryopoiesis [105–107].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [105]
Citations
Cites
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F. A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., et al. (2001) · Blood · doi:10.1182/blood.v98.9.2720 · Cited by 667 · cited 1×
“In vitro and in vivo studies confirmed this suggestion, in that they showed that Interleukin-6 (IL-6), an acutephase response mediator, stimulates TPO transcription in the liver and increases TPO blood levels, which in turn induces thrombocytosis [8, 9].”
ResultThe molecular mechanisms that control thrombopoiesis
Kaushansky, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26674 · Cited by 570 · cited 1×
“An inverse relationship between platelet count and TPO therefore exists in healthy subjects [1].”
BackgroundPhysiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.
de Sauvage, F. J., Carver-Moore, K., Luoh, S. M., Ryan, A., Dowd, M., Eaton, D. L., & Moore, M. W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.651 · Cited by 423 · cited 1×
“Thus, both in humans and mice other haematopoietic cytokines, not yet completely identified, contribute to thrombopoiesis in non-physiological conditions [14].”
BackgroundHarker, L. A., Roskos, L. K., Marzec, U. M., Carter, R. A., Cherry, J. K., Sundell, B., Cheung, E. N., Terry, D., & Sheridan, W. (2000) · Blood · doi:10.1182/blood.v95.8.2514 · Cited by 228 · cited 1×
“levels lower than those usually measured in unselected healthy people [15, 16].”
BackgroundAledort, L. M., Hayward, C. P. M., Chen, M., Nichol, J. L., & Bussel, J. (2004) · American Journal of Hematology · doi:10.1002/ajh.20104 · Cited by 191 · cited 1×
“levels lower than those usually measured in unselected healthy people [15, 16].”
BackgroundRelationships between platelets and inflammatory markers in rheumatoid arthritis
Milovanovic, M., Nilsson, E., & Järemo, P. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.12.030 · Cited by 140
Thrombopoietin levels in patients with primary and reactive thrombocytosis
Cerutti, A., Custodi, P., Duranti, M., Noris, P., & Balduini, C. L. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3823196.x · Cited by 130 · cited 1×
“A notable exception is represented by reactive thrombocytosis, where levels of the hormone higher than expected have been detected [2].”
BackgroundSelf-citationBeer, J. H., Büchi, L., & Steiner, B. (1994) · Blood · doi:10.1182/blood.v83.3.691.691 · Cited by 99
Heits, F., Stahl, M., Ludwig, D., Stange, E. F., & Jelkmann, W. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313604 · Cited by 86 · cited 1×
“Some studies of small case series of subjects in the post-operative period [3, 4] or with inflammatory bowel diseases [5], rheumatoid arthritis [6] or infections [7] suggested that TPO behaves as an acute-phase protein and that its increase is responsible for thrombocytosis.”
BackgroundSteinberg, M. H., Kelton, J. G., & Coller, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171701 · Cited by 73 · cited 2×
“In fact, GC is a soluble fragment of platelet glycoprotein Ib and its level reflects platelet turnover [12, 13].”
BackgroundSepsis severity is the major determinant of circulating thrombopoietin levels in septic patients
Zakynthinos, S. G., Papanikolaou, S., Theodoridis, T., Zakynthinos, E. G., Christopoulou-Kokkinou, V., Katsaris, G., & Mavrommatis, A. C. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000121433.61546.a0 · Cited by 69 · cited 1×
“Some studies of small case series of subjects in the post-operative period [3, 4] or with inflammatory bowel diseases [5], rheumatoid arthritis [6] or infections [7] suggested that TPO behaves as an acute-phase protein and that its increase is responsible for thrombocytosis.”
BackgroundCirculating thrombopoietin in reactive conditions behaves like an acute phase reactant
Cerutti, A., Custodi, P., Mduranti, Cazzola, M., & Balduini, C. L. (1999) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.1999.00226.x · Cited by 53 · cited 1×
“Some studies of small case series of subjects in the post-operative period [3, 4] or with inflammatory bowel diseases [5], rheumatoid arthritis [6] or infections [7] suggested that TPO behaves as an acute-phase protein and that its increase is responsible for thrombocytosis.”
BackgroundSelf-citationThe role of thrombopoietin in post‐operative thrombocytosis
Folman, C. C., Ooms, M., Kuenen, B. C., de Jong, S. M., Vet, R. J. W. M., de Haas, M., & Borne, A. E. G. K. V. D. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02888.x · Cited by 49 · cited 1×
“Some studies of small case series of subjects in the post-operative period [3, 4] or with inflammatory bowel diseases [5], rheumatoid arthritis [6] or infections [7] suggested that TPO behaves as an acute-phase protein and that its increase is responsible for thrombocytosis.”
BackgroundThrombopoietin Production in Wild-Type and Interleukin-6 Knockout Mice with Acute Inflammation
Burmester, H., Wolber, E.-M., Freitag, P., Fandrey, J., & Jelkmann, W. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.407 · Cited by 35 · cited 1×
“In vitro and in vivo studies confirmed this suggestion, in that they showed that Interleukin-6 (IL-6), an acutephase response mediator, stimulates TPO transcription in the liver and increases TPO blood levels, which in turn induces thrombocytosis [8, 9].”
ResultPatients with thrombocytosis have normal or slightly elevated thrombopoietin levels.
Español, I., Hernández, A., Cortés, M., Mateo, J., & Pujol‐Moix, N. (1999) · PubMed · Cited by 31
Rous, P., & Lange, L. B. (1913) · The Journal of Experimental Medicine · doi:10.1084/jem.18.6.651 · Cited by 29
Robinson, M. S. C., Machin, S. J., Mackie, I. J., & Harrison, P. (2001) · Platelets · doi:10.1080/09537100020047093 · Cited by 12 · cited 7×
“ESRc, erythrocyte sedimentation rate corrected for hematocrit; CRP, C-reactive protein; IL-6, interleukin-6; TPO, thrombopoietin; PLT, platelet count; GC, glycocalicin; GCI, Glycocalicin Index.”
MethodInfluential
Research works printed but not linked: 1
- Español I, 1999, Haematologica, 84, 312
Cited by
Santimone, I., Di Castelnuovo, A., De Curtis, A., Spinelli, M., Cugino, D., Gianfagna, F., Zito, F., Donati, M. B., Cerletti, C., de Gaetano, G., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.043042 · Cited by 186
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Increased cord serum inflammatory markers in small-for-gestational-age neonates
Amarilyo, G., Oren, A., Mimouni, F. B., Ochshorn, Y., Deutsch, V., & Mandel, D. (2010) · Journal of Perinatology · doi:10.1038/jp.2010.53 · Cited by 128
Azab, B. N., Torbey, E., Singh, J., Akerman, M. B., Khoueiry, G., McGinn, J. T., Widmann, W. D., & Lafferty, J. (2011) · Platelets · doi:10.3109/09537104.2011.584086 · Cited by 135
“Many studies have demonstrated the association between elevated platelet count in inflammatory conditions and higher levels of interleukin-6 [31, 32], and tumor necrosis factor [33].”
BackgroundBonaccio, M., Castelnuovo, A. F. D., Curtis, A. D., Costanzo, S., Persichillo, M., Donati, M. B., Cerletti, C., Iacoviello, L., & de Gaetano, G. (2014) · Blood · doi:10.1182/blood-2013-12-541672 · Cited by 125
Metadata
- Authors
- Ceresa, I. F., Noris, P., Ambaglio, C., Pecci, A., & Balduini, C. L.
- Affiliations
- University of Pavia (IT)
- Corresponding author
- Balduini, Carlo L.
- Venue
- Platelets
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 18
- Issue
- 8
- Pages
- 579-582
- ISSN
- 0953-7104 (ISSN-L)
- 1369-1635
- OpenAlex
- W2044466822
- Cited by
- 58
- References
- 17
- Citations by year
- 2025: 3 · 2023: 4 · 2022: 7 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 3 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 3
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Platelets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Myeloproliferative Neoplasms: Diagnosis and Treatment
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- thrombopoietin, reactive thrombocytosis, inflammatory diseases, acute phase proteins, interleukin-6, C-reactive protein, erythrocyte sedimentation rate, platelet count, acute phase response
- MeSH terms
- Acute-Phase Reaction, Aged, Aged, 80 and over, Blood Sedimentation, C-Reactive Protein, Female, Humans, Inflammation, Male, Middle Aged, Platelet Count, Thrombocytosis, Thrombopoietin, Interleukin-6, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.